When Alzheimer's is LATE: Why Does it Matter?

被引:23
|
作者
Nelson, Peter T. [1 ,2 ,3 ]
Schneider, Julie A. [4 ,5 ]
Jicha, Gregory A. [3 ,6 ]
Duong, Michael Tran [7 ]
Wolk, David A. [7 ]
机构
[1] Univ Kentucky, Alzheimers Dis Res Ctr, 575 Lee Todd Bldg,789 S Limestone, Lexington, KY 40536 USA
[2] Univ Kentucky, Dept Pathol, Lexington, KY USA
[3] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY USA
[4] Rush Univ, Dept Pathol, Med Coll, Chicago, IL USA
[5] Rush Univ, Med Coll, Dept Neurol Sci, Chicago, IL USA
[6] Univ Kentucky, Dept Neurol, Lexington, KY USA
[7] Univ Penn, Dept Neurol, Philadelphia, PA USA
关键词
HIPPOCAMPAL SCLEROSIS; TDP-43; IMMUNOREACTIVITY; DISEASE; PATHOLOGY; BRAIN; ENCEPHALOPATHY; ASSOCIATION; IMPAIRMENT; ATROPHY; AD;
D O I
10.1002/ana.26711
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Recent therapeutic advances provide heightened motivation for accurate diagnosis of the underlying biologic causes of dementia. This review focuses on the importance of clinical recognition of limbic-predominant age-related TDP-43 encephalopathy (LATE). LATE affects approximately one-quarter of older adults and produces an amnestic syndrome that is commonly mistaken for Alzheimer's disease (AD). Although AD and LATE often co-occur in the same patients, these diseases differ in the protein aggregates driving neuropathology (A beta amyloid/tau vs TDP-43). This review discusses signs and symptoms, relevant diagnostic testing, and potential treatment implications for LATE that may be helpful for physicians, patients, and families. ANN NEUROL 2023
引用
收藏
页码:211 / 222
页数:12
相关论文
共 50 条
  • [41] Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy (PART) and Alzheimer's disease
    Bell, W. Robert
    An, Yang
    Kageyama, Yusuke
    English, Collin
    Rudow, Gay L.
    Pletnikova, Olga
    Thambisetty, Madhav
    O'Brien, Richard
    Moghekar, Abhay R.
    Albert, Marilyn S.
    Rabins, Peter V.
    Resnick, Susan M.
    Troncoso, Juan C.
    ALZHEIMERS & DEMENTIA, 2019, 15 (01) : 8 - 16
  • [42] White matter hyperintensity topography in Alzheimer's disease and links to cognition
    Garnier-Crussard, Antoine
    Bougacha, Salma
    Wirth, Miranka
    Dautricourt, Sophie
    Sherif, Siya
    Landeau, Brigitte
    Gonneaud, Julie
    De Flores, Robin
    de la Sayette, Vincent
    Vivien, Denis
    Krolak-Salmon, Pierre
    Chetelat, Gael
    ALZHEIMERS & DEMENTIA, 2022, 18 (03) : 422 - 433
  • [43] Genetic discoveries and advances in late-onset Alzheimer's disease
    Rezazadeh, Maryam
    Hosseinzadeh, Hassan
    Moradi, Mohsen
    Esfahani, Behnaz Salek
    Talebian, Shahrzad
    Parvin, Shaho
    Gharesouran, Jalal
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (10) : 16873 - 16884
  • [44] Soluble amyloid beta levels are elevated in the white matter of Alzheimer's patients, independent of cortical plaque severity
    Collins-Praino, Lyndsey E.
    Francis, Yitshak I.
    Griffith, Erica Y.
    Wiegman, Anne F.
    Urbach, Jonathan
    Lawton, Arlene
    Honig, Lawrence S.
    Cortes, Etty
    Vonsattel, Jean Paul G.
    Canoll, Peter D.
    Goldman, James E.
    Brickman, Adam M.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2014, 2
  • [45] Concomitant LATE-NC in Alzheimer's disease is not associated with increased tau or amyloid-β pathological burden
    McAleese, K. E.
    Walker, L.
    Erskine, D.
    Johnson, M.
    Koss, D.
    Thomas, A. J.
    Attems, J.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2020, 46 (07) : 722 - 734
  • [46] Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid β
    Mormino, Elizabeth C.
    Papp, Kathryn V.
    Rentz, Dorene M.
    Donohue, Michael C.
    Amariglio, Rebecca
    Quiroz, Yakeel T.
    Chhatwal, Jasmeer
    Marshall, Gad A.
    Donovan, Nancy
    Jackson, Jonathan
    Gatchel, Jennifer R.
    Hanseeuw, Bernard J.
    Schultz, Aaron P.
    Aisen, Paul S.
    Johnson, Keith A.
    Sperling, Reisa A.
    ALZHEIMERS & DEMENTIA, 2017, 13 (09) : 1004 - 1012
  • [47] White Matter and Neuroprotection in Alzheimer's Dementia
    Lorenzini, Luca
    Fernandez, Mercedes
    Baldassarro, Vito Antonio
    Bighinati, Andrea
    Giuliani, Alessandro
    Calza, Laura
    Giardino, Luciana
    MOLECULES, 2020, 25 (03):
  • [48] Why does the Aβ peptide of Alzheimer share structural similarity with antimicrobial peptides?
    Pastore, Annalisa
    Raimondi, Francesco
    Rajendran, Lawrence
    Temussi, Piero Andrea
    COMMUNICATIONS BIOLOGY, 2020, 3 (01)
  • [49] Decreased white matter integrity in late-myelinating fiber pathways in Alzheimer's disease supports retrogenesis
    Stricker, N. H.
    Schweinsburg, B. C.
    Delano-Wood, L.
    Wierenga, C. E.
    Bangen, K. J.
    Haaland, K. Y.
    Frank, L. R.
    Salmon, D. P.
    Bondi, M. W.
    NEUROIMAGE, 2009, 45 (01) : 10 - 16
  • [50] Gray matter volume in women with the BRCA mutation with and without ovarian removal: evidence for increased risk of late-life Alzheimer's disease or dementia
    Witt, Suzanne T.
    Brown, Alana
    Gravelsins, Laura
    Engstrom, Maria
    Classon, Elisabet
    Lykke, Nina
    Avall-Lundqvist, Elisabeth
    Theordorsson, Elvar
    Ernerudh, Jan
    Kjolhede, Preben
    Einstein, Gillian
    MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY, 2024, 31 (07): : 608 - 616